» Articles » PMID: 33469989

REST Promotes ETS1-dependent Vascular Growth in Medulloblastoma

Abstract

Expression of the RE1-silencing transcription factor (REST), a master regulator of neurogenesis, is elevated in medulloblastoma (MB) tumors. A cell-intrinsic function for REST in MB tumorigenesis is known. However, a role for REST in the regulation of MB tumor microenvironment has not been investigated. Here, we implicate REST in remodeling of the MB vasculature and describe underlying mechanisms. Using REST mice, we demonstrate that elevated REST expression in cerebellar granule cell progenitors, the cells of origin of sonic hedgehog (SHH) MBs, increased vascular growth. This was recapitulated in MB xenograft models and validated by transcriptomic analyses of human MB samples. REST upregulation was associated with enhanced secretion of proangiogenic factors. Surprisingly, a REST-dependent increase in the expression of the proangiogenic transcription factor E26 oncogene homolog 1, and its target gene encoding the vascular endothelial growth factor receptor-1, was observed in MB cells, which coincided with their localization at the tumor vasculature. These observations were confirmed by RNA-Seq and microarray analyses of MB cells and SHH-MB tumors. Thus, our data suggest that REST elevation promotes vascular growth by autocrine and paracrine mechanisms.

Citing Articles

REST Is Restless in Neuronal and Non-Neuronal Virus Infections: An In Silico Analysis-Based Perspective.

Pillai V, Ravindran S, Krishna G, Abhinand C, Nelson-Sathi S, Veettil M Viruses. 2025; 17(2).

PMID: 40006989 PMC: 11860772. DOI: 10.3390/v17020234.


KIF15 promotes human glioblastoma progression under the synergistic transactivation of REST and P300.

Yu W, Han S, Hu S, Ru L, Hua C, Xue G Int J Biol Sci. 2024; 20(13):5127-5144.

PMID: 39430242 PMC: 11488581. DOI: 10.7150/ijbs.98668.


REST-dependent downregulation of von Hippel-Lindau tumor suppressor promotes autophagy in SHH-medulloblastoma.

Singh A, Cheng D, Swaminathan J, Yang Y, Zheng Y, Gordon N Sci Rep. 2024; 14(1):13596.

PMID: 38866867 PMC: 11169471. DOI: 10.1038/s41598-024-63371-7.


Angiogenesis-related lncRNAs index: A predictor for CESC prognosis, immunotherapy efficacy, and chemosensitivity.

Huang X, Yi G, Xu J, Gou S, Chen H, Chen X J Cancer. 2024; 15(10):3095-3113.

PMID: 38706901 PMC: 11064265. DOI: 10.7150/jca.94332.


REST Is Not Resting: REST/NRSF in Health and Disease.

Jin L, Liu Y, Wu Y, Huang Y, Zhang D Biomolecules. 2023; 13(10).

PMID: 37892159 PMC: 10605157. DOI: 10.3390/biom13101477.


References
1.
Gopalakrishnan V, Tao R, Dobson T, Brugmann W, Khatua S . Medulloblastoma development: tumor biology informs treatment decisions. CNS Oncol. 2015; 4(2):79-89. PMC: 4408195. DOI: 10.2217/cns.14.58. View

2.
Bonney P, Santucci J, Maurer A, Sughrue M, McNall-Knapp R, Battiste J . Dramatic response to temozolomide, irinotecan, and bevacizumab for recurrent medulloblastoma with widespread osseous metastases. J Clin Neurosci. 2016; 26:161-3. DOI: 10.1016/j.jocn.2015.10.022. View

3.
Ballas N, Grunseich C, Lu D, Speh J, Mandel G . REST and its corepressors mediate plasticity of neuronal gene chromatin throughout neurogenesis. Cell. 2005; 121(4):645-657. DOI: 10.1016/j.cell.2005.03.013. View

4.
Robinson M, Maximov V, Lallani S, Farooq H, Taylor M, Read R . Upregulation of the chromatin remodeler HELLS is mediated by YAP1 in Sonic Hedgehog Medulloblastoma. Sci Rep. 2019; 9(1):13611. PMC: 6754407. DOI: 10.1038/s41598-019-50088-1. View

5.
Cho Y, Tsherniak A, Tamayo P, Santagata S, Ligon A, Greulich H . Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome. J Clin Oncol. 2010; 29(11):1424-30. PMC: 3082983. DOI: 10.1200/JCO.2010.28.5148. View